Mapping local functional activity by measurement of local cerebral glucose utilization in the central nervous system of animals and man.
D015107:4-Butyrolactone / Q000494:pharmacology; D000375:Aging; D000818:Animals; D001345:Autoradiography; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism*; D003847:Deoxyglucose / Q000031:analogs & derivatives / Q000378:metabolism; D004734:Energy Metabolism; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism*; D012739:Gonadal Steroid Hormones / Q000494:pharmacology; D006309:Hearing; D006801:Humans; D000860:Hypoxia / Q000378:metabolism; D008954:Models, Biological; D009021:Morphine Dependence / Q000378:metabolism; D010904:Pituitary Gland, Posterior / Q000502:physiology; D011954:Receptors, Dopamine / Q000187:drug effects; D012640:Seizures / Q000378:metabolism; D012683:Sensory Deprivation; D012725:Sexual Behavior; D013565:Sympatholytics / Q000494:pharmacology; D013961:Thyroid Gland / Q000502:physiology; D014785:Vision, Ocular
D012739:Gonadal Steroid Hormones; D011954:Receptors, Dopamine; D013565:Sympatholytics; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose; D005947:Glucose; D015107:4-Butyrolactone